The latest closing stock price for Monopar Therapeutics as of November 20, 2024 is 19.00.
An investor who bought $1,000 worth of Monopar Therapeutics stock at the IPO in 2019 would have $-857 today, roughly -1 times their original investment - a -32.19% compound annual growth rate over 5 years.
The all-time high Monopar Therapeutics stock closing price was 135.00 on December 20, 2019.
The Monopar Therapeutics 52-week high stock price is 38.50, which is 102.6% above the current share price.
The Monopar Therapeutics 52-week low stock price is 1.37, which is 92.8% below the current share price.
The average Monopar Therapeutics stock price for the last 52 weeks is 4.41.
An investor who bought $1,000 worth of Monopar Therapeutics stock at the IPO in 2019 would have $-857 today, roughly -1 times their original investment - a -32.19% compound annual growth rate over 5 years.
The all-time high Monopar Therapeutics stock closing price was 135.00 on December 20, 2019.
The Monopar Therapeutics 52-week high stock price is 38.50, which is 102.6% above the current share price.
The Monopar Therapeutics 52-week low stock price is 1.37, which is 92.8% below the current share price.
The average Monopar Therapeutics stock price for the last 52 weeks is 4.41.